Novel Preclinical Tools for Predictive ADME-Toxicology

The summary for the Novel Preclinical Tools for Predictive ADME-Toxicology grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Novel Preclinical Tools for Predictive ADME-Toxicology: The NIH invites grant applications to support the development, standardization, and validation of novel approaches to obtain comprehensive absorption, distribution, metabolism, excretion (ADME) and toxicological (TOX) profiles that could better predict how new molecular entities will perform in humans to reduce the failure rate in clinical testing. This is an NIH Roadmap initiative. This funding opportunity will use the R21 Exploratory/Developmental Research Grants award mechanism. This RFA solicits applications that explore novel, high-risk, and high-impact approaches to achieve this goal, rather than incremental technology development that is already supported by current NIH programs.

Federal Grant Title:	Novel Preclinical Tools for Predictive ADME-Toxicology
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-04-023
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Biomedical Research and Research Training
Current Application Deadline:	No deadline provided
Original Application Deadline:	Jan 25, 2005
Posted Date:	Nov 23, 2004
Creation Date:	Nov 23, 2004
Archive Date:	Feb 24, 2005
Total Program Funding:	$2,000,000
Maximum Federal Grant Award:	$250,000
Minimum Federal Grant Award:
Expected Number of Awards:	4
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34); • Maximizing Access to Research Careers (MARC) (T34); • Medical Scientist Training Program (MSTP) (T32); • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed); • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...